Sign in

Patrick J. Lord

Executive Vice President, Chief Operating Officer at LAM RESEARCH
Executive

About Patrick J. Lord

Patrick J. Lord, Ph.D., is Executive Vice President and Chief Operating Officer (COO) of Lam Research, a role he has held since March 1, 2023; he is 59 years old as of August 2025 and holds B.S., M.S., and Ph.D. degrees in mechanical engineering from MIT . His remit spans Global Operations; Customer Support; Global Quality; Environmental Health & Safety; Global Government Affairs & Trade; Information Technology; Cybersecurity; and Global Resilience, Security & Transformation, reflecting broad operational accountability and risk management oversight . Under his tenure, Lam’s calendar-year 2024 revenue was approximately $16.2B (+13% y/y), with operating cash flow of ~$4.6B (28% of revenues), while FY2025 reported net income of ~$340M and non-GAAP operating margin of 32.3%, aligning his incentive metrics to profitability and TSR outcomes .

Past Roles

OrganizationRoleYearsStrategic Impact
Lam ResearchEVP & COOMar 2023–presentExpanded remit to include GIS and Global Resilience/Security/Transformation; drive operational effectiveness, productivity, and business resilience .
Lam ResearchEVP, CSBG & Global OperationsSep 2020–Feb 2023Led Customer Support Business Group and global operations, integrating lifecycle support with cost/quality initiatives .
Lam ResearchSVP & GM, CSBGDec 2016–Sep 2020Scaled CSBG revenues and offerings across spares, refurbishment and upgrades to optimize uptime and cost for customers .
Lam ResearchGroup VP & Deputy GM, Global Products GroupSep 2013–Dec 2016Product design/engineering governance across etch/deposition; business processes for cost, quality, volume, reliability .
Lam Research (via Novellus acquisition)Head of DGSI Business UnitsJun 2012–Sep 2013Led Direct Metals, GapFill, Surface Integrity Group & Integrated Metals units following Novellus acquisition .
Novellus SystemsSVP & GM, DGSI; SVP BD & Strategic Planning2001–2012Business development, strategic planning, and BU leadership across CMP, DGSI; senior roles in marketing and product .
KLA-TencorProduct marketing/management roles~1995–2001Product marketing and management across inspection/metrology, pre-Lam career foundation .

External Roles

OrganizationRoleYearsStrategic Impact
Novellus SystemsVarious senior roles incl. SVP/GM, BD & Strategic Planning2001–2012Grew multiple process BUs and strategic planning capabilities prior to Lam acquisition .
KLA-TencorProduct marketing/management~1995–2001Market-led product management experience in inspection/metrology .

Fixed Compensation

MetricCY 2023CY 2024CY 2025
Base Salary ($)577,661 685,000 725,000
Target Bonus (% of Base)110% 110% 110%
Target Bonus ($)635,427 753,500 797,500
Actual AIP Paid ($)610,010 922,510

Calendar 2024 AIP mechanics and payout (Dr. Lord)

ComponentMetricWeightingTarget level designActual ResultFactor Applied
Funding Factornon-GAAP operating marginN/ASets max pool funding250.0% of target pool2.50x
Corporate Performance Factornon-GAAP operating margin1/3Stretch goal above AOP; scaled more rapidly around AOP for 2024Achieved1.06
Profitability Performance Factornon-GAAP gross margin1/3Stretch goal above AOP; scaled more rapidly around AOP for 2024Achieved1.10
Individual Performance FactorCorporate & individual goals1/3Weighted corporate plan contribution, individual contribution, corporate modifierAverage for NEOs1.05
Dr. Lord payout ($)Computed2024 target $753,500Result$922,510

Performance Compensation

LTIP structure and grants

ProgramVehicleMetricMix (% of LTIP target)Grant/Performance DatesVestingGrant Details (Dr. Lord)
2025/2027 LTIPMarket-based PRSUsRelative TSR vs XSOX (percentile rank); capped at 100% if absolute TSR negative60% (EVP) Grant 2/28/2025; Performance 2/3/2025–2/2/2028 Cliff at 3 years40,565 target PRSUs
2025/2027 LTIPService-based RSUsService40% (EVP) Grant 2/28/20251/3 vest on 1st, 2nd, 3rd anniversaries27,043 RSUs
2022/2024 LTIP payoutMarket-based PRSUsTSR vs XSOX (index comparison)Performance 2/1/2022–1/31/2025 56.94% of target; 17,309 shares paid

Market-based PRSU payout curve (2025/2027)

TSR Percentile vs XSOXEarned (% of Target)
≥75th percentile150%
50th percentile100%
25th percentile50%
<25th percentile0%

Options and vesting schedules

Grant DateExercisable (#)Unexercisable (#)Exercise PriceVesting Convention
3/1/202410,610 21,220 $98.15 1/3 annually for 3 years
3/1/202314,070 14,070 $49.09 1/3 annually for 3 years
3/1/202210,130 $54.06 Fully vested; original 3-year schedule

Equity Ownership & Alignment

ItemValue
Beneficial ownership (shares)71,455; <1% of class (outstanding shares 1,261,032,300)
Shares vest/exercisable within 60 days34,810 (options/RSUs)
Unvested RSUs (2/28/2025 grant)27,043; market value $2,628,580 at $97.20 closing price
Market-based PRSUs (target, 2/28/2025 grant)40,565; target payout value $3,942,918 at $97.20
Stock ownership guideline (EVP)2× base salary; executive officers in compliance or have time remaining
Hedging/pledgingProhibited under insider trading policy .

Alignment notes

  • LTIP is majority performance-based (relative TSR) with explicit negative-TSR cap, increasing sensitivity to shareholder outcomes .
  • AIP uses profitability (non-GAAP operating margin and gross margin) plus corporate/individual goals, reinforcing focus on margin discipline .

Employment Terms

Executive Severance & Change-in-Control (CIC) Economics (Tier 1 – EVP)

ScenarioCash SeveranceShort-term IncentiveEquity TreatmentBenefits/Other
Involuntary (not for cause), no CIC/Acquisition100% of base salary; 150% for CEO 50% of Five-Year Average; plus pro-rata current-year incentive (corporate results; individual at target/peer-average) Pro-rata vesting of performance RSUs (cash based on performance to date × stock price); pro-rata vesting of service RSUs/options granted ≥12 months prior Medical continuation; confidentiality/non-compete; release; 6-month non-solicit .
Disability/DeathPro-rata current-year incentive (corporate results; individual at target/peer-average) N/AVesting of service RSUs/options; pro-rata performance RSUs based on performance to date Medical continuation .
CIC or Acquisition (double trigger)150% of base; 150% of Five-Year Average; plus pro-rata Five-Year Average in year of termination (200% multiples for CEO) As above Service RSUs/options granted prior to CIC: vest at termination; Performance RSUs: cash award = pro-rata performance to CIC + pro-rata target to period end × stock price Medical continuation; release; 6-month non-solicit .

Potential Payments Illustration (as of 6/29/2025; Dr. Lord)

ScenarioTotal ($)
Involuntary – Not for Cause7,459,099
CIC or Acquisition (Double Trigger)18,559,011
Disability/Death17,720,425

Governance/Policy Provisions

  • Clawback: SEC/Nasdaq-compliant policy (effective 2023), recoupment of incentive-based compensation upon restatement regardless of fault; supersedes prior policy .
  • Tax gross-ups: No gross-ups for perquisites/CIC; relocation gross-ups may apply broadly (example shown for another NEO) .
  • Option repricing: Prohibited without shareholder approval .
  • Insider trading: Hedging/pledging prohibited; blackout periods in effect .

Performance Compensation – Detailed AIP Table (CY 2024)

MetricWeightTargeting ApproachActual vs TargetPayout Factor
non-GAAP operating margin (Corporate)33.3%Stretch goals above AOP; accelerated scaling between AOP and “1.0” level (2024 only)Achieved stretch1.06
non-GAAP gross margin (Profitability)33.3%Stretch goals above AOP; accelerated scaling between AOP and “1.0” level (2024 only)Achieved stretch1.10
Individual Performance33.3%Corporate plan contribution + individual contributions + corporate modifierAvg. applied to NEOs1.05

Compensation Structure Analysis

  • Shift from options to RSUs: 2025/2027 LTIP removed options, increasing service RSU mix while keeping market-based PRSUs constant; committee cited resilience amid stock volatility and peer alignment .
  • Negative TSR cap: PRSU payouts capped at 100% if absolute TSR is negative, limiting upside in down markets .
  • AIP complexity reverted: 2025 AIP returns to linear factor relationships (removing 2024 accelerated scaling) to reduce complexity while maintaining stretch goals .
  • Strong Say-on-Pay: Advisory approvals exceeded 90% from 2021–2024, signaling investor support for pay design .

Equity Ownership & Pledging

  • Ownership guidelines: EVP 2× salary; all NEOs in compliance or within the allowed time window to reach compliance .
  • Pledging/hedging: Prohibited by policy, reducing alignment risk; exchange fund participation limited and diversified .
  • Related-party transactions: None reported for executives in FY2025, reducing conflict risk .

Expertise & Qualifications

  • Technical/operator: Nearly three decades across semiconductor equipment operations and product leadership; prior senior roles at Novellus; product/marketing roles at KLA-Tencor; MIT-trained engineer .
  • COO remit: Cross-functional leadership including cybersecurity and government affairs/trade, aligning with Lam’s risk and compliance scope .
  • Appointment details: Named COO effective March 1, 2023; no special arrangements; no family relationships or related transactions .

Investment Implications

  • High alignment: Majority performance-based LTIP tied to relative TSR with negative-TSR cap, AIP anchored to operating and gross margin, and strict hedging/pledging prohibitions support shareholder alignment .
  • Realized performance signal: 2022/2024 PRSU payout of 56.94% (underperforming XSOX) indicates realistic calibration and payout discipline; near-term RSU vesting and options schedules provide predictable supply, with some options deeply in-the-money and others near current pricing .
  • Retention economics: Double-trigger CIC and pro-rata vesting mechanics reduce windfall risk while providing retention; severance multiples for EVPs are moderate vs peers, with clawback overlay mitigating restatement risk .
  • Business performance backdrop: CY2024 revenue growth (+13% y/y to ~$16.2B) and FY2025 non-GAAP margin (32.3%) tie directly to AIP profitability metrics, reinforcing management focus on margin and cash generation .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%